**Core Concept**
Cryoprecipitate is a concentrated solution of labile coagulation factors, including fibrinogen, factor VIII, and von Willebrand factor. It is derived from the plasma of donors who have been screened for infectious diseases and is used to treat bleeding disorders and patients with coagulopathy.

**Why the Correct Answer is Right**
Cryoprecipitate is rich in fibrinogen, which is essential for clot formation and stabilization. When blood is cooled, the fibrinogen molecules precipitate out of solution, allowing for the concentration of these labile coagulation factors. Cryoprecipitate is used to treat conditions such as hypofibrinogenemia, which can occur in patients with liver disease, sepsis, or disseminated intravascular coagulation (DIC). The fibrinogen in cryoprecipitate also has a role in the formation of fibrin clots, which are essential for wound healing and hemostasis.

**Why Each Wrong Option is Incorrect**
**Option A:** While platelets are essential for primary hemostasis, cryoprecipitate is not a rich source of platelets.

**Option B:** Factor VII is a vitamin K-dependent coagulation factor, but it is not concentrated in cryoprecipitate.

**Option C:** Factor XIII is a transglutaminase that stabilizes fibrin clots, but it is not a primary component of cryoprecipitate.

**Clinical Pearl / High-Yield Fact**
Cryoprecipitate is often used as a component of fresh frozen plasma (FFP) in patients with coagulopathy. FFP is a more diluted product than cryoprecipitate, but it contains a broader range of coagulation factors.

**Correct Answer: D. Fibrinogen.**